I-Mab (NASDAQ:IMAB) Q2 2023 Earnings Call Transcript

I-Mab (NASDAQ:IMAB) Q2 2023 Earnings Call Transcript August 17, 2023

Tyler Ehler: Good morning, everyone, and thank you for joining us this morning and for standing by. I’d like to take this opportunity to welcome you all to the I-Mab Biopharma Mid-Year 2023 Financial Results and Business Update Conference Call. My name is Tyler Ehler, and I’m I-Mab’s Senior Director for Investor Relations. At this time, all participants are in a listen-only mode. At end of this call, we will conduct a Q&A...